Hypertension Research
Online ISSN : 1348-4214
Print ISSN : 0916-9636
Clinical studies
Green Coffee Bean Extract Improves Human Vasoreactivity
Ryuji OCHIAIHiroko JOKURAAtsushi SUZUKIIchiro TOKIMITSUMitsuru OHISHINorio KOMAIHiromi RAKUGIToshio OGIHARA
Author information
JOURNALS FREE ACCESS

2004 Volume 27 Issue 10 Pages 731-737

Details
Abstract

Our previous study revealed the antihypertensive effects of green coffee bean extract (GCE) ingestion in spontaneously hypertensive rats. We suggested that this antihypertensive action was due to the fact that GCE contains chlorogenic acid (CQA) as a major phenolic compound, and CQA in turn contains ferulic acid as a metabolic component that acts on nitric oxide (NO) derived from the vascular endothelium. In this study, the effects of GCE on blood vessels were evaluated in healthy males. The subjects were 20 healthy males with reduced vasodilation responses measured by strain gauge plethysmograms (SPG) to ischemic reactive hyperemia. Of the 20 subjects, 10 (mean age, 37.2 years) ingested a test drink containing GCE (CQA: 140 mg/day), and the other 10 (mean age, 34.8 years) ingested a placebo drink for 4 months. During the ingestion period, SPG, pulse wave velocity (PWV), and serum biochemical parameters were measured, and acceleration plethysmograms (APG) were taken. The reactive hyperemia ratio (RHR) in the test drink group began to increase after ingestion for 1 month and was significantly higher (p <0.05) than that in the placebo group after ingestion for 3 months and 4 months. In addition, after ingestion for 4 months, the test drink group showed a significant decrease (p <0.01) in the plasma total homocysteine level compared with the pre-ingestion level. However, there were no significant differences in PWV or APG between the test drink group and the placebo drink group. The improvement in RHR after ingestion of a drink containing GCE suggested an improvement in vasoreactivity by this component. (Hypertens Res 2004; 27: 731-737)

Information related to the author
© 2004 by the Japanese Society of Hypertension
Previous article Next article
feedback
Top